Jennifer P. Morton

24.7k total citations · 5 hit papers
100 papers, 9.5k citations indexed

About

Jennifer P. Morton is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Jennifer P. Morton has authored 100 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Oncology, 46 papers in Molecular Biology and 18 papers in Immunology. Recurrent topics in Jennifer P. Morton's work include Pancreatic and Hepatic Oncology Research (39 papers), Cancer Cells and Metastasis (16 papers) and Cancer-related Molecular Pathways (15 papers). Jennifer P. Morton is often cited by papers focused on Pancreatic and Hepatic Oncology Research (39 papers), Cancer Cells and Metastasis (16 papers) and Cancer-related Molecular Pathways (15 papers). Jennifer P. Morton collaborates with scholars based in United Kingdom, United States and Australia. Jennifer P. Morton's co-authors include Owen J. Sansom, Saadia A. Karim, Paul Timpson, Valerie G. Brunton, Stephen B. Dunnett, Nigel B. Jamieson, Rachel A. Ridgway, Karin A. Oien, Kurt I. Anderson and Margaret C. Frame and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Jennifer P. Morton

97 papers receiving 9.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

2009 1.4k citations Valerie G. Brunton, Jennifer P. Morton et al. profile →
p53 status determines the role of autophagy in pancreatic tumour development

2013 576 citations Jennifer P. Morton, Colin Nixon et al. profile →
The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration

2017 479 citations Jennifer P. Morton, Owen J. Sansom et al. profile →
Matrix stiffness induces epithelial–mesenchymal transition and promotes chemoresistance in pancreatic cancer cells

2017 401 citations Saadia A. Karim, Jennifer P. Morton et al. profile →
Therapeutic targeting of tumour myeloid cells

2023 168 citations Simon T. Barry, Owen J. Sansom et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jennifer P. Morton United Kingdom	51	5.2k	3.9k	2.3k	1.4k	1.3k	100	9.5k
Rolf Bjerkvig Norway	59	6.3k 1.2×	3.4k 0.9×	3.3k 1.4×	1.2k 0.9×	1.5k 1.1×	235	12.7k
Fumiaki Tanaka Japan	68	9.2k 1.8×	2.9k 0.7×	3.1k 1.3×	1.6k 1.1×	1.2k 0.9×	360	15.8k
Marcus Bosenberg United States	61	7.0k 1.4×	4.7k 1.2×	2.0k 0.9×	3.6k 2.6×	1.4k 1.0×	177	12.6k
Tan A. Ince United States	42	6.2k 1.2×	2.3k 0.6×	1.3k 0.5×	726 0.5×	792 0.6×	73	9.1k
Massimiliano Mazzone Belgium	52	6.6k 1.3×	3.2k 0.8×	3.7k 1.6×	3.7k 2.6×	840 0.6×	164	12.9k
Jean J. Zhao United States	48	8.1k 1.6×	4.1k 1.0×	1.8k 0.8×	1.4k 1.0×	773 0.6×	114	12.6k
Laura E. Benjamin United States	38	6.9k 1.3×	2.6k 0.7×	2.8k 1.2×	955 0.7×	1.1k 0.8×	70	10.8k
Xiao‐Jing Wang United States	48	5.6k 1.1×	3.2k 0.8×	1.4k 0.6×	1.5k 1.0×	1.0k 0.8×	179	9.7k
Andréas Bikfalvi France	52	5.0k 1.0×	1.8k 0.5×	1.6k 0.7×	998 0.7×	1.5k 1.1×	182	8.3k
Yasufumi Sato Japan	55	7.3k 1.4×	1.8k 0.5×	2.4k 1.0×	907 0.7×	1.4k 1.1×	261	11.1k

Countries citing papers authored by Jennifer P. Morton

Since Specialization

Citations

This map shows the geographic impact of Jennifer P. Morton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer P. Morton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer P. Morton more than expected).

Fields of papers citing papers by Jennifer P. Morton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer P. Morton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer P. Morton. The network helps show where Jennifer P. Morton may publish in the future.

Co-authorship network of co-authors of Jennifer P. Morton

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer P. Morton. A scholar is included among the top collaborators of Jennifer P. Morton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer P. Morton. Jennifer P. Morton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Evans, Alice C., Simei Go, Tess A. Stanly, et al.. (2025). Induction of macrophage efferocytosis in pancreatic cancer via PI3Kγ inhibition and radiotherapy promotes tumour control. Gut. 74(5). 825–839. 5 indexed citations

Tesson, Mathias, Katrina H. Stevenson, Saadia A. Karim, et al.. (2024). Targeted irradiation in an autochthonous mouse model of pancreatic cancer. Disease Models & Mechanisms. 17(3). 1 indexed citations

Najumudeen, Arafath K., Sigrid K. Fey, Catriona A. Ford, et al.. (2024). KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo. Nature Communications. 15(1). 100–100. 8 indexed citations

Go, Simei, Sophie Hughes, Helen Ferry, et al.. (2024). Tissue-resident natural killer cells support survival in pancreatic cancer through promotion of cDC1-CD8 T activity. eLife. 13. 2 indexed citations

Sandilands, Emma, Álvaro Román‐Fernández, Susan Mason, et al.. (2021). An ARF GTPase module promoting invasion and metastasis through regulating phosphoinositide metabolism. Nature Communications. 12(1). 1623–1623. 10 indexed citations

Nielsen, Sebastian R., Edward R. Horton, René Jackstadt, et al.. (2021). Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade. Nature Communications. 12(1). 3414–3414. 89 indexed citations

Heinrich, Marcel Alexander, et al.. (2021). Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models. Advanced Drug Delivery Reviews. 174. 265–293. 78 indexed citations

Morton, Jennifer P., et al.. (2021). Heterogeneity in Pancreatic Cancer Fibroblasts—TGFβ as a Master Regulator?. Cancers. 13(19). 4984–4984. 8 indexed citations

Mitchell, Louise, Kirsteen J. Campbell, Rachel A. Ridgway, et al.. (2019). Brf1 loss and not overexpression disrupts tissues homeostasis in the intestine, liver and pancreas. Cell Death and Differentiation. 26(12). 2535–2550. 6 indexed citations

10.

Allen-Petersen, Brittany L., Tyler Risom, Zipei Feng, et al.. (2018). Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma. Cancer Research. 79(1). 209–219. 62 indexed citations

11.

Conway, James R. W., et al.. (2018). Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine. Gut. 68(4). 742–758. 65 indexed citations

12.

Warren, Sean, Max Nobis, Astrid Magenau, et al.. (2018). Removing physiological motion from intravital and clinical functional imaging data. eLife. 7. 31 indexed citations

13.

Driscoll, David R., Saadia A. Karim, Makoto Sano, et al.. (2016). mTORC2 Signaling Drives the Development and Progression of Pancreatic Cancer. Cancer Research. 76(23). 6911–6923. 58 indexed citations

14.

Arjonen, Antti, Riina Kaukonen, Elina Mattila, et al.. (2014). Mutant p53–associated myosin-X upregulation promotes breast cancer invasion and metastasis. Journal of Clinical Investigation. 124(3). 1069–1082. 134 indexed citations

15.

Nobis, Max, Ewan J. McGhee, Jennifer P. Morton, et al.. (2013). Intravital FLIM-FRET Imaging Reveals Dasatinib-Induced Spatial Control of Src in Pancreatic Cancer. Cancer Research. 73(15). 4674–4686. 99 indexed citations

16.

Denley, S, Nigel B. Jamieson, Karin A. Oien, et al.. (2013). Activation of the IL-6R/Jak/Stat Pathway is Associated with a Poor Outcome in Resected Pancreatic Ductal Adenocarcinoma. Journal of Gastrointestinal Surgery. 17(5). 887–898. 79 indexed citations

17.

Timpson, Paul, Ewan J. McGhee, Jennifer P. Morton, et al.. (2011). Spatial Regulation of RhoA Activity during Pancreatic Cancer Cell Invasion Driven by Mutant p53. Cancer Research. 71(3). 747–757. 109 indexed citations

18.

Jamieson, Nigel B., Jennifer P. Morton, Asif Ali, et al.. (2011). MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 18(2). 534–545. 175 indexed citations

19.

Morton, Jennifer P., Paul Timpson, Saadia A. Karim, et al.. (2009). Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proceedings of the National Academy of Sciences. 107(1). 246–251. 465 indexed citations

20.

Arvanitis, Demetrios A., Jennifer A. Fairley, Natividad Gomez-Roman, et al.. (2004). Deregulation of RNA polymerase III transcription in cervical epithelium in response to high-risk human papillomavirus. Oncogene. 24(5). 880–888. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact